The nation's trade deficit narrowed more than expected in December to boost the markets to a higher open with the Dow gaining 67 points to 14,011. Nasdaq climbed 27 points to 3192.
On the upside
Oncolytics Biotech (Nasdaq: ONCY) reported positive results from a midstage clinical trial of its lung cancer treatment Reolysin.
Activision Blizzard (Nasdaq: ATVI) reported sharply higher fourth quarter earnings and revenue that topped analyst estimates.
LinkedIn (NYSE: LNKD) reported higher fourth quarter earnings that surpassed analyst expectations by a wide margin as revenue surged.
On the downside
Nuance Communications (Nasdaq: NUAN) fell to a loss for the first quarter and forecast full year results below expectations prompting downgrades.
EnteroMedics (Nasdaq: ETRM) reported disappointing results from a Phase III study of its implantable weight loss device VBLOC.
Fourth quarter earnings tumbled for Riverbed Technology (Nasdaq: RVBD) due to acquisition related costs and the network gear maker forecast current quarter earnings below expectations.
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 3 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 index gained 7 points to 1517.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here